Aardvark Therapeutics, Inc. (AARD) vs Nautilus Biotechnology, Inc. (NAUT)

Aardvark Therapeutics, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Aardvark Therapeutics, Inc. and Nautilus Biotechnology, Inc. are of similar size ($126.1M and $121.5M). Across the 9 metrics below, Nautilus Biotechnology, Inc. leads on 7 and Aardvark Therapeutics, Inc. on 2.

Valuation

Metric AARD NAUT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.48 0.94 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (63.44%) (46.39%) (28.84%)
Free cash flow yield (62.88%) (42.05%) (23.03%)

Profitability

Metric AARD NAUT Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (66.02%) (36.21%) (57.72%)
Return on assets (61.06%) (30.00%) (49.22%)
Return on invested capital (4,986.18%) (83.32%) 0.00%

Growth

Metric AARD NAUT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 43.11% 16.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AARD NAUT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.63 10.14 4.73
Net debt to EBITDA 1.72 1.67 0.96

Dividend

Metric AARD NAUT Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric AARD NAUT Biotechnology median
Market cap 121.46m 126.05m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack